Processa Pharmaceuticals, Inc. (PCSA) Financials
PCSA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 8.1 million | 914847 |
2023-06-30 | 10.1 million | 930741 |
2023-03-31 | 12.4 million | 2.3 million |
2022-12-31 | 8.6 million | 1.1 million |
PCSA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -1.8 million | 142894 |
2023-06-30 | -2.1 million | 319123 |
2023-03-31 | -2.1 million | 341504 |
2022-12-31 | -2.5 million | 2.8 million |
PCSA Net Income
No data available :(
PCSA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 6.9 million | - | 171521 |
2023-06-30 | 8.7 million | - | 191217 |
2023-03-31 | 10.7 million | - | 210524 |
2022-12-31 | 6.5 million | - | 229450 |
PCSA Shares Outstanding
PCSA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 2776 | 1.2 million | 1.0 million | - |
2023-06-30 | - | 1.7 million | 1.0 million | - |
2023-03-31 | - | 1.6 million | 2.5 million | - |
2022-12-31 | - | 3.2 million | 2.6 million | - |
PCSA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 2.2 million |
2023-06-30 | - | 2.7 million |
2023-03-31 | - | 4.1 million |
2022-12-31 | - | 216515 |
PCSA
Price: $2.17
52 week price:
Earnings Per Share: -22.80 USD
P/E Ratio: -0.11
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 125600
Market Capitalization: 3.1 million